Kresmion signals archive
974 cross-asset signals fired across commodity, crypto, equity, forex, macro. See also the Kresmion brief for 2026-05-02.
commodity (3)
OSINT: Energy commodity prices surge over 70% since Jan 1, 2026
CFTC 4 speculator at extreme long — contrarian bear signal
CFTC 1 speculator at extreme short — contrarian bull signal
crypto (3)
BTC ETF outflow of $165M — institutional selling
ETH ETF outflow of $177M — institutional selling
USDC/USDT has $65.2M volume but only $884K liquidity — thin market, slippage risk
equity (194)
FDA approves drug (Pfizer) — new revenue stream
FDA approves LINEZOLID (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves SYNAREL (Pfizer) — new revenue stream
FDA approves MEDROL (Pfizer) — new revenue stream
FDA approves HEMABATE (Pfizer) — new revenue stream
FDA approves HEMABATE (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves NORPACE CR (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves CYKLOKAPRON (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves HEMABATE (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves LINEZOLID (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves MEDROL (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves COLESTID (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves ZYVOX (Pfizer) — new revenue stream
FDA approves NORPACE CR (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves ZYVOX (Pfizer) — new revenue stream
FDA approves SYNAREL (Pfizer) — new revenue stream
FDA approves ZYVOX (Pfizer) — new revenue stream
FDA approves ZYVOX (Pfizer) — new revenue stream
FDA approves COLESTID (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves CYKLOKAPRON (Pfizer) — new revenue stream
FDA approves SYNAREL (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves CYKLOKAPRON (Pfizer) — new revenue stream
FDA approves NORPACE CR (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves ZYVOX (Pfizer) — new revenue stream
FDA approves LINEZOLID (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves MEDROL (Pfizer) — new revenue stream
FDA approves VELSIPITY (Pfizer) — new revenue stream
FDA approves COLESTID (Pfizer) — new revenue stream
FDA approves ZYVOX (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves VELSIPITY (Pfizer) — new revenue stream
FDA approves drug (Pfizer) — new revenue stream
FDA approves VELSIPITY (Pfizer) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves CANCIDAS (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves CANCIDAS (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves CANCIDAS (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Merck) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves INSULIN LISPRO (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves INSULIN LISPRO (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves EVISTA (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves EVISTA (Lilly) — new revenue stream
FDA approves EVISTA (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves HUMATROPE (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves HUMATROPE (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves ALIMTA (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves HUMATROPE (Lilly) — new revenue stream
FDA approves ALIMTA (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves ALIMTA (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves drug (Lilly) — new revenue stream
FDA approves INSULIN LISPRO (Lilly) — new revenue stream
FDA approves TRUVADA (Gilead) — new revenue stream
FDA approves drug (Gilead) — new revenue stream
FDA approves CAYSTON (Gilead) — new revenue stream
FDA approves TRUVADA (Gilead) — new revenue stream
FDA approves CAYSTON (Gilead) — new revenue stream
FDA approves EMTRIVA (Gilead) — new revenue stream
FDA approves drug (Gilead) — new revenue stream
FDA approves EMTRIVA (Gilead) — new revenue stream
FDA approves EMTRIVA (Gilead) — new revenue stream
FDA approves EMTRIVA (Gilead) — new revenue stream
FDA approves EMTRIVA (Gilead) — new revenue stream
FDA approves drug (Gilead) — new revenue stream
FDA approves LETAIRIS (Gilead) — new revenue stream
FDA approves CAYSTON (Gilead) — new revenue stream
FDA approves LETAIRIS (Gilead) — new revenue stream
FDA approves EMTRIVA (Gilead) — new revenue stream
FDA approves LETAIRIS (Gilead) — new revenue stream
FDA approves TRUVADA (Gilead) — new revenue stream
FDA approves CAMZYOS (Bristol) — new revenue stream
FDA approves CAMZYOS (Bristol) — new revenue stream
FDA approves drug (Bristol) — new revenue stream
FDA approves SOTYKTU (Bristol) — new revenue stream
FDA approves SOTYKTU (Bristol) — new revenue stream
FDA approves ONUREG (Bristol) — new revenue stream
FDA approves ONUREG (Bristol) — new revenue stream
FDA approves drug (Bristol) — new revenue stream
FDA approves drug (Bristol) — new revenue stream
FDA approves POMALYST (Bristol) — new revenue stream
FDA approves POMALYST (Bristol) — new revenue stream
FDA approves POMALYST (Bristol) — new revenue stream
FDA approves EVOTAZ (Bristol) — new revenue stream
FDA approves ONUREG (Bristol) — new revenue stream
FDA approves EVOTAZ (Bristol) — new revenue stream
FDA approves EVOTAZ (Bristol) — new revenue stream
FDA approves CAMZYOS (Bristol) — new revenue stream
FDA approves drug (Bristol) — new revenue stream
FDA approves AVONEX (Biogen) — new revenue stream
FDA approves AVONEX (Biogen) — new revenue stream
FDA approves drug (Biogen) — new revenue stream
FDA approves drug (Biogen) — new revenue stream
FDA approves drug (Biogen) — new revenue stream
FDA approves PROLIA (Amgen) — new revenue stream
FDA approves PROLIA (Amgen) — new revenue stream
FDA approves PROLIA (Amgen) — new revenue stream
FDA approves NPLATE (Amgen) — new revenue stream
FDA approves NPLATE (Amgen) — new revenue stream
FDA approves NPLATE (Amgen) — new revenue stream
FDA approves VECTIBIX (Amgen) — new revenue stream
FDA approves VECTIBIX (Amgen) — new revenue stream
FDA approves VECTIBIX (Amgen) — new revenue stream
